Moderna Inc
(MRNA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,561,000 | -4,714,000 | 8,362,000 | 12,202,000 | -747,000 |
| Depreciation Amortization | 94,000 | 560,000 | 379,000 | 286,000 | 41,000 |
| Income taxes - deferred | N/A | N/A | N/A | -318,000 | N/A |
| Accounts receivable | 534,000 | 493,000 | 1,790,000 | -1,784,000 | -1,385,000 |
| Accounts payable and accrued liabilities | -69,000 | 13,000 | 240,000 | 204,000 | 12,000 |
| Other Working Capital | -78,000 | 689,000 | -4,014,000 | 1,308,000 | 2,578,000 |
| Other Operating Activity | 76,000 | -159,000 | -1,776,000 | 1,722,000 | 1,528,000 |
| Operating Cash Flow | $-3,004,000 | $-3,118,000 | $4,981,000 | $13,620,000 | $2,027,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,051,000 | -707,000 | -400,000 | -284,000 | -68,000 |
| Net Acquisitions | N/A | -85,000 | N/A | N/A | N/A |
| Purchase Of Investment | -6,529,000 | -3,783,000 | -11,475,000 | -12,682,000 | -2,956,000 |
| Sale Of Investment | 9,529,000 | 8,781,000 | 6,699,000 | 4,443,000 | 1,352,000 |
| Investing Cash Flow | $1,949,000 | $4,206,000 | $-5,176,000 | $-8,523,000 | $-1,672,000 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | -6,000 |
| Common Stock Issued | 66,000 | 46,000 | 65,000 | 124,000 | 2,039,000 |
| Common Stock Repurchased | N/A | -1,153,000 | -3,329,000 | -857,000 | N/A |
| Other Financing Activity | -10,000 | -270,000 | -184,000 | -140,000 | 0 |
| Financing Cash Flow | $56,000 | $-1,377,000 | $-3,448,000 | $-873,000 | $2,033,000 |
| Beginning Cash Position | 2,928,000 | 3,217,000 | 6,860,000 | 2,636,000 | 248,000 |
| End Cash Position | 1,929,000 | 2,928,000 | 3,217,000 | 6,860,000 | 2,636,000 |
| Net Cash Flow | $-999,000 | $-289,000 | $-3,643,000 | $4,224,000 | $2,388,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,004,000 | -3,118,000 | 4,981,000 | 13,620,000 | 2,027,000 |
| Capital Expenditure | -1,051,000 | -707,000 | -400,000 | -284,000 | -68,000 |
| Free Cash Flow | -4,055,000 | -3,825,000 | 4,581,000 | 13,336,000 | 1,959,000 |